PMC3636957_01
PMC3636957_02
PMC3636957_03
CT scans of a long-term NSCLC survivor a after chemotherapy (CT of the thorax was assessed as 'normal' - the lesion in the right upper lobe was assessed as calcified), b during disease progression and c during stable disease after long-term treatment with erlotinib.
cro-0006-0189-g01.jpg
PMC3636957_05_cro-0006-0189-g01.jpg
F1
The patient has had no non-pleural metastases (fig. 1c).
PMC3636957_04
CT scans of a long-term NSCLC survivor a after chemotherapy (CT of the thorax was assessed as 'normal' - the lesion in the right upper lobe was assessed as calcified), b during disease progression and c during stable disease after long-term treatment with erlotinib.
cro-0006-0189-g01.jpg
PMC3636957_05_cro-0006-0189-g01.jpg
F1
The patient has had no non-pleural metastases (fig. 1c).
PMC3636957_05
CT scans of a long-term NSCLC survivor a after chemotherapy (CT of the thorax was assessed as 'normal' - the lesion in the right upper lobe was assessed as calcified), b during disease progression and c during stable disease after long-term treatment with erlotinib.
cro-0006-0189-g01.jpg
PMC3636957_05_cro-0006-0189-g01.jpg
F1
The patient has had no non-pleural metastases (fig. 1c).